venetoclax,azacitidine,emavusertib
roche,curis,abbvie
['emavusertib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'mds']
oncology news update: 'eha 2022: targeted therapy emavusertib shows encouraging activity in mds and aml with specific mutations' has been published on oncology news australia - #oncnews 
Creating Innovative Resources for the Australian Oncology Community and Beyond. Home of The Oncology Newsletter, The Oncology Podcast and https://t.co/xBVIOdvL7D